India : Business News Headlines – 22 Sep 2016
Business Standard
Ø US Federal Reserve keeps key rate unchanged
Ø CAD narrows to $300mn in Q1 on import contraction
Ø Pricing of 700 MHz spectrum band expensive: Mittal
Ø India, China may escape worst of global environment: UNCTAD
Ø Sebi asks NSE to take stock of possible wrongdoing
Ø Rel Defence in talks to sell vessels to Coast Guard
Ø IOC, GAIL to take 49% stake in Adani Group’s project
Ø OECD sees globalisation brake on growth
Ø Cabinet clears conversion of R&C loan into equity
Ø Govt irked by Moody’s statement on ratings upgrade
Ø Sebi to auction Sahara group’s 13 more land parcels
Ø Cabinet approves closing down Hindustan Diamonds
Ø ICICI Prudential IPO oversubscribed 10 times
Ø Nestle seeks SC nod to destroy 550 tonnes of Maggi Noodles
Business Line
Ø Cabinet approves Rs. 1,250 cr subsidy to BSNL
Ø Govt extends stock limits on pulses, edible oils by one year
Ø YES Bank invokes ₹156-crore pledged United Breweries shares
Ø Seafood industry has a rosy future, says MPEDA chief
Ø Steel demand likely to grow 5.3% this fiscal
Ø Essel Propack buys out partner’s stake in JV firm
Mint
Ø Rupee closes little changed against US dollar
Ø Adani unveils world’s largest solar plant in Tamil Nadu
Ø Govt set to fund eastern gas pipeline project
Ø Suzlon plans to raise $3 billion for Australian wind farms by 2020
Ø Cabinet approves purchase of 36 Rafale fighter jets: report
Ø Private equity upbeat on retail commercial space in India
Financial Express
Ø Markets in wait and watch mode ahead of US Fed outcome
Ø Marine exports likely to rise 20% to $5.6 billion in 2016-17: Govt
Ø NTPC gets shareholders’ nod to raise up to Rs15k cr via bonds
Ø Tata Communications tests UHD broadcast at Singapore F1 race
Ø SAIL eyes sales of 14.52 MT in FY’17; production of 17.16 MT
Financial Chronicle
Ø Cabinet approves merging of Rail budget with Union Budget
Ø Stockholding cap on pulses, edible oils extended
Ø BOJ rate surprise lifts world stocks ahead of Fed
Ø Federal Reserve expected to keep rates unchanged
Ø CIL gears up for double-digit production growth
Ø Aurobindo Pharma, Cadila recall drugs from US market
